More time for blood culturing device compliance in US:
This article was originally published in Clinica
The US FDA has extended the compliance date for the rule revoking the exemption from the requirement to obtain premarket clearance for blood culturing system devices. The new date is December 26th, 1996. For further information, contact: Lisa Rooney at the CDRH. Tel: +1 (301) 594 4765, ext 164.
You may also be interested in...
Previous businesses FDA warned about COVID-19 claims for chlorine dioxide, a bleach solution, were marketing dietary supplements unlawfully. But Pro Breath MD's oral rinses available under the Dentist Select and OraCare brands are allowed and FDA isn’t asking the firm to discontinue distribution.
The Stark Law ban on self-referrals wouldn’t apply to some physician owners of advanced imaging facilities under a CMS final rule.
Pfizer’s abrocitinib and Biogen/Eisai’s aducanumab are among a host of new investigational products that are under review by the European Medicines Agency.